Clinical Report: Expanding Surgical Options for Liver Cancer and Metastases

Overview

A UCI Health physician discussion describes evolving surgical and liver-directed approaches for primary liver tumors and colorectal liver metastases. Topics include minimally invasive resection, staged or repeat surgery, hepatic arterial infusion chemotherapy, and methods to optimize the future liver remnant; the discussion emphasizes specialized multidisciplinary evaluation for selected patients with advanced disease.

Background

Primary liver cancers and metastatic tumors involving the liver may be considered for surgery in selected cases, including some patients with advanced disease. The source describes the liver's regenerative capacity as relevant to complex procedures and discusses portal vein embolization and future liver remnant optimization. It also identifies multidisciplinary planning, including specialized hepatobiliary and anesthesia teams, as part of surgical evaluation. The discussion focuses on expanding consideration of surgical options rather than providing numerical outcomes or treatment recommendations.

Data Highlights

The supplied article context and transcript description contain no numerical trial results or quantitative outcome data.

Key Findings

• The discussion covers both primary liver cancers and metastatic tumors involving the liver, particularly colorectal liver metastases.
• Robotic and laparoscopic liver resection are discussed, including potential benefits for recovery.
• Staged and repeat liver resections are described as treatment strategies for selected patients with colorectal liver metastases.
• Hepatic arterial infusion chemotherapy is discussed as an approach to downstage initially unresectable liver metastases.
• Portal vein embolization and future liver remnant optimization are among the techniques discussed to prepare for surgery.
• The physicians emphasize collaborative planning and specialized evaluation when considering potentially curative treatment for select patients with advanced disease.

Clinical Implications

The source describes specialized hepatobiliary evaluation and multidisciplinary surgical planning as important when assessing whether patients with primary or metastatic liver tumors may be candidates for surgery. It presents minimally invasive resection, liver-directed therapies, staged procedures, and liver remnant optimization as approaches discussed for selected patients, without specifying eligibility criteria or comparative outcomes.

Conclusion

The discussion presents a range of surgical and liver-directed strategies that may be considered for selected patients with primary liver cancer or colorectal liver metastases. It highlights specialized, collaborative evaluation as central to identifying potential treatment options.

Related Resources & Content

1. UCI Health, Physician discussion, n.d. — Expanding surgical options for liver cancer and liver metastases
2. ASCO Publications, 2017 — Role of surgery for gastric cancer with liver limited multiple metastases
3. Wagman LD, Journal of Clinical Oncology, 2008 — Expanded Criteria for Surgery for Liver Metastases: Thoughtful Science or Diamond Mining?
4. ASCO Publications — Expanded Criteria for Surgery for Liver Metastases: Thoughtful Science or Diamond Mining?
5. Minimally Invasive Liver Resection: Clinical Indications, Challenges, and Financial Considerations
6. Role of surgery for gastric cancer with liver limited multiple metastases
7. Expanded Criteria for Surgery for Liver Metastases: Thoughtful Science or Diamond Mining?
8. Immune Checkpoint Inhibitors plus Anti-VEGF/Tyrosine Kinase Inhibitors Combined with TACE (Triple Therapy) in Unresectable Hepatocellular Carcinoma - PMC
9. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆ - Annals of Oncology
10. Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study - PMC